Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Barry J. Crevey"'
Autor:
Kyong T. Turk, Michael Watts, Charles J. Love, John Schutzman, Charles L. Byrd, Russell Reeves, Heidi J. Van Zandt, Joey Trantham, Neal E. Fearnot, Roger A. Freedman, Frank Gold, Barry J. Crevey, Steven P. Kutalek, John Wilson, Raymond Young, T. Duncan Sellers, Jess W. Oren, Richard A. Friedman, Bruce L. Wilkoff
Publikováno v:
Pacing and Clinical Electrophysiology. 22:1348-1357
Of the 400,000-500,000 permanent pacemaker leads implanted worldwide each year, around 10% may eventually fail or become infected, becoming potential candidates for removal. Intravascular techniques for removing problematic or infected leads evolved
Publikováno v:
The American Journal of Medicine. 90:725-729
Purpose To determine the relative potency in healthy individuals of the vagally mediated reflexes used clinically to inhibit sinoatrial and atrioventricular node function. Subjects and methods Twenty healthy volunteers with no history of heart diseas
Autor:
Scott A. Boschee, Barry J. Crevey, William J. Groh, William M. Miles, M. Erick Burton, Erica D. Engelstein, Douglas P. Zipes, Peter R. Foster
Publikováno v:
Circulation. 100(4)
Background —In patients with implantable cardioverter-defibrillators (ICDs). inappropriate shocks have been reported with exposure to electronic article surveillance systems. The risk to patients with ICDs of walking through or lingering near surve
Publikováno v:
Pacing and Clinical Electrophysiology. 15:1637-1638
From February 1988 until August 1991, 28 patients with prior coronary artery bypass grafting (CABG) received implantable cardioverter defibrillator (ICD) therapy via a subxiphoid approach. Only one patient required conversion to a median sternotomy i
Publikováno v:
The American Journal of Cardiology. 53:B112-B119
Effective antiarrhythmic therapy requires a carefully considered approach, including an understanding of the arrhythmia, the underlying cardiac disease and the drug's pharmacokinetics. Flecainide is a new antiarrhythmic drug that may soon be released
Autor:
Mary Kay Foley, John M. Nicklas, Lorenzo A. DiCarlo, Thomas M. Annesley, Jeffrey M. Baerman, Fred Morady, Barry J. Crevey
Publikováno v:
American Heart Journal. 111:644-648
The interrelationships between serum levels of amiodarone, desethylamiodarone, and reverse T3, and changes in the corrected QT interval (delta QTc) were examined in 22 patients during long-term treatment with amiodarone. At 1, 3, and 6 months of foll
Publikováno v:
The Journal of the American Osteopathic Association. 83:69-74
Autor:
William H. Kou, S Schmaltz, Theresa A. Johnson, Michael de Buitleir, Steven D. Nelson, Barry J. Crevey, Fred Morady
Publikováno v:
American Heart Journal. 116:379-384
Pirmenol is an investigational type 1A antiarrhythmic drug the long-term efficacy of which has not been fully determined. Therefore the long-term efficacy of oral pirmenol in suppressing ventricular premature depolarizations (VPDs) was assessed in an
Publikováno v:
The American Journal of Cardiology. 49:578-583
In studies of five patients treated with acute intravenous administration of diltiazem, hemodynamic improvement occurred in the four patients with precapillary pulmonary hypertension. This was manifested by modest declines in pulmonary arterial press
Autor:
Barry J. Crevey, Jeffrey M. Baerman, Ryszard B. Krol, Sunil K. Das, Michael de Buitleir, Fred Morady, Lorenzo A. DiCarlo
Publikováno v:
The American Journal of Cardiology. 58:998-1000
Twenty-four patients, mean age 42 years, with idiopathic dilated cardiomyopathy (DC) and no history of symptomatic ventricular arrhythmias underwent right ventricular programmed stimulation with up to 3 extrastimuli. Ventricular tachycardia (VT) was